PHDS Co

About PHDS Co

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-02-11
  Phds Co publishes dosimetry data at SNMMI 2026
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• FierceBiotech · 2026-09-04
  Phds Co closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-12-05
  Phds Co partners with academic center on Actinium-225 program
  The work builds on more than a decade of radiochemistry collaboration.
• Reuters Health · 2026-07-06
  Phds Co files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-06-27
  Phds Co announces Phase II readout for lead theranostic candidate
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.